Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients
M.-C. Boll; M. Alcaraz-Zubeldia; C. Rios; D. González-Esquivel; S. Montes;
10.1016/j.nrleng.2022.07.003
Design and validation of a questionnaire for monitoring neurological dysphagia and respiratory deterioration in patients with amyotrophic lateral sclerosis (DEREDELA)
S. Bermudo Fuenmayor; P.J. Serrano Castro; P. Quiroga Subirana; S. López Palmero; M.M. Requena Mullor; T. Parrón Carreño;
Neurologia. 2024;39:666-74
The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis
J.J. Martínez-Payá; J. Ríos-Díaz; M.E. del Baño-Aledo; D. Hervás; J.I. Tembl-Ferrairó; T. Sevilla-Mantecón; J.F. Vázquez-Costa;
Neurologia. 2024;39:564-72